您的位置: 首页 > 农业专利 > 详情页

Hetero ring compound
专利权人:
Astellas Pharma Inc.
发明人:
Shiwaku, Masahiko,Takahashi, Fumie,Imada, Sunao,Asano, Toru,Kozuki, Yoshihiro,Maeda, Junko,Kato, Koji,Fukahori, Hidehiko
申请号:
AU2011290189
公开号:
AU2011290189B2
申请日:
2011.08.09
申请国别(地区):
AU
年份:
2015
代理人:
摘要:
[Problem]To provide a compound which is useful as a novel and excellent prophylactic and/or therapeutic agent for rejection in various types of organ transplantation, allergic diseases, autoimmune diseases and blood tumors, and which acts in a manner relying on a PI3Kδ-selective inhibitory activity and/or an IL-2-production-inhibiting activity and/or a B-cell-proliferation-inhibiting activity (including an activation-inhibiting activity).[Solution]Examination was made on compounds each having a PI3Kδ-selective inhibitory activity and/or an IL-2-production-inhibiting activity and/or a B-cell-proliferation-inhibiting activity (including an activation-inhibiting activity), and it has been confirmed that a hetero ring compound having a chemical structure represented by formula (I) has a PI3Kδ-selective inhibitory activity and/or an IL-2-production-inhibiting activity and/or a B-cell-proliferation-inhibiting activity (including an activation-inhibiting activity).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充